TapImmune Inc. | |
Stock Exchange | Other OTC |
EPS |
$1.35 |
Market Cap |
$111.85 M |
Shares Outstanding |
13.62 M |
Public Float |
12.12 M |
Address |
5 West Forsyth Street Jacksonville Florida 32202 United States |
Employees | - |
Website | http://www.tapimmune.com |
Updated | 09/14/2018 |
TapImmune, Inc. is an immuno-oncology company, which engages in the development of technologies for the treatment of cancer, including metastasis, and infectious diseases. It also involves in developing vaccines for breast, colorectal, ovarian, and non-small cell lung cancer. The company was founded in 1991 and is headquartered in Jacksonville, FL. |